loader image

Old Issuances

Date
Issuance
Title
10 January 2000Administrative Order No. 3-A s. 2000Guidelines on Vitamin A and Iron Supplementation
7 January 2000Administrative Order No. 3-B s. 2000Guidelines for Assistance/Sponsorship by Manufacturers of Products Covered by Executive Order 51 (Milk Code)
11 December 2000Administrative Order No. 163-B s. 2000Revised Schedule of Fees and Charges for the services rendered by the Bureau of Food and Drugs
24 January 2001Administrative Order No. 177 s. 2001Amendment to Administrative Order No.117 s. 2000 Relative to the Guidelines on the Accreditation of Suppliers of Medical Equipment, Parts, Accessories and Medical Equipment Repair Shop
02 December 2003Administrative Order No. 119 s. 2003Updated Guidelines on Micronutrient Supplementation (Vitamin A, Iron, and Iodine)
03 September 2003Administrative Order No. 82 s. 2003Guidelines on the Granting of Diamond Sangkap Pinoy Seal to Manufacturers of Fortified Products
06 June 2003Administrative Order No. 54-A s. 2003Guidelines on the Processing and Clearance of Importations through Donations by the Department of Health
12 November 2004Administrative Order No. 177 s. 2004Amendment to Administrative Order No.171 s. 2004 on the Policies and Guidelines to Implement the Relevant Provisions of Republic Act 9257, Otherwise Known as the Expanded Senior Citizens Act of 2003
01 October 2004Administrative Order No. 171 s. 2004Policies and Guidelines to Implement the Relevant Provisions of Republic Act 9257, Otherwise Known as the "Expanded Senior Citizens Act of 2003"
06 September 2004Administrative Order No. 169 s. 2004Implementing Guidelines for the Exclusive Use of Generic Names or Generic Terminology in all Prescriptions and Orders in all DOH Facilities
07 May 2004Administrative Order No. 153 s. 2004Revised Guidelines on Current Good Manufacturing Practice in Manufacturing, Packing, Repacking or Holding Food
09 January 2004Administrative Order No. 134 s. 2004Guidelines Governing the Registration and Performance Evaluation of Drug Screening Test Kits and Reagents
03 January 2005Administrative Order No. 2005-0001Revised Policies and Guidelines Governing Patent and Trade Secret Rights in relation to the Registration of Pharmaceutical Products
07 March 2006Administrative Order No. 2005-0003-B Amendment to AO 2005-0003 dated January 11, 2005 re: Guidelines on the Issuance of Certificate of Product Registration for Water Purification Equipment and Device
08 June 2009Administrative Order No. 2005-0003-CAddendum to Administrative Order No. 2005-0003 " Guidelines on the Issuance of Certificate of Product Registration for Water Purification Equipment and Device"
31 March 2005Administrative Order No. 2005-0007Amending Administrative Order No.142, s.2004 by Providing Exemption from the Requirement of Certificate of Product Registration for All Goods Procured Through UNICEF, UNDP WHO, and GDF
Administrative Order No. 2005-0008Policy and Requirements for Availing of Special Permit for Restricted Use of Unregistered Drug and Test Kits for Human Immune Deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
04 April 2005Administrative Order No. 2005-0011Supplemental -Guidelines to Administrative Order No. 144 Series 2004, Entitled ".Guidelines for the Establishment and Operations of Botika ng ''Barangays (BnB) and Pharmaceutical Distribution (PDNs)" Relative to the Inclusion of Other Drugs which are Classified as Prescription Drugs and other Related Matters
06 October 2005Administrative Order No. 2005-0025Implementation of the ASEAN Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents
07 December 2005Administrative Order No. 2005-0030 Guidelines and Procedure For the Automatic Renewal of the Certificate of Product Registration issued by the Bureau of Food and Drugs
07 December 2005Administrative Order No. 2005-0031Guidelines and Procedure For the Issuance of the Principal Certificate of Product Registration and the Listing of Identical Drug Products based on the Identity of Manufacturer and Pharmaceutical Formulation
08 January 2007Administrative Order No. 2007-0003Policies and Guidelines Governing the Registration and Licensing of Establishments Dealing with Medical Devices
14 March 2007Administrative Order No. 2007-0014Guidelines on the Issuance of Certificate of Product Registration for Equipment or Devices Used for Trating Sharps, Pathological and Infectious Waste
30 July 2008Administrative Order No. 2008-0021 Gradual Phase-out of Mercury in All Philippine Health Care Facilities and Institutions
22 October 2008Administrative Order No. 2008-0030Renaming the National Codex Committee (NCC) to the National Codex Organization (NC0) and Amending Its Terms of Reference (TOR)
18 March 2010Administrative Order No. 2010-0008Directive Specific to the Change in the Use of Phrase "No Approved Therapeutic Claim" in all Advertisement, Promotional, and/or Sponsorship Activities or Materials Concerning Food/Dietary Supplements
11 October 2013Administrative Order No. 2013-0031 Requirements for the Operation of a Therapeutic X-ray Facility Utilizing Medical Linear Accelerators
11 April 2014Administrative Order No. 2014-0016Adoption of the World Health Organization "Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs)" for the Registration of Biosimilar Products"
13 October 2014Administrative Order No. 2014-0034Administrative Order No.2014-0034 || Rules and Regulations on the Licensing of Establishments Engaged in the Manufacture, Conduct of Clinical Trial, Distribution, Importation, Exportation, and Retailing of Drug Products, and Issuance of Other Related Authorizations
27 October 2014Administrative Order No. 2014-0038Rules and Regulation Governing Household / Urban Pesticides Licensing of Establishment and Operators, Registration of Their Products and for Other Purpose
27 October 2014Administrative Order No. 2014-0040REVISED GUIDELINE ON THE NEED / ROLE OF A MEDICAL DIRECTOR IN THE PHARMACEUTICAL INDUSTRY
Administrative Order No. 2014-0042Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines
08 September 2015Administrative Order No. 2015-0038REMOVING THE REQUIREMENTS OF LICENSING AS IMPORTERS, EXPORTERS, MANUFACTURERS, TOLL MANUFACTURERS, WHOLESALERS, DISTRIBUTORS, RETAILERS, OR RE-PACKERS OF THOSE ENGAGE IN CERTAIN HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES, AND FROM THE REQUIREMENT OF PRIOR REGISTRATION AND/OR NOTIFICATION OF SAID PRODUCTS
15 February 2016Administrative Order No. 2016-0003Guidelines on the Unified Licensing Requirements and Procedure of the Food and Drug Administration (FDA)
02 March 2016Administrative Order No. 2016-0008Revised Rules and Regulations Governing the Generic Labeling Requirements of Drug Products for Human Use
23 June 2017Administrative Order No. 2017-0010Philippine National Standards for Drinking Water of 2017
14 June 2019Administrative Order No. 2019-0007 Revised Rules and Regulations on Electronic Nicotine and Non-Nicotine Delivery System (ENDS/ENNDS)
04 June 2018Administrative Order No. 2018-0016Revised Guidelines in the Implementation of the One-Stop Shop Licensing System
08 May 2020Administrative Order No. 2020-0017Revised Guidelines on the Unified Licensing Requirements and Procedures of the Food and Drug Administration Repealing Administrative Order No. 2016-0003
06 March 2020Administrative Order No. 2020-0010Regulations on the Conduct of Clinical Trials for Investigational Products
08 July 2010FDA Memorandum Circular No.2010-012Republic Act No. 9442 and Its Implementing Rules and Regulations
18 October 2010FDA Memorandum Circular No.2010-019Suspension of Manufacture, Importation, Distribution, and/or Marketing of Sibutramine Products
18 October 2010FDA Memorandum Circular No.2010-020 Suspension of Manufacture, Importation, Distribution, and/or Marketing of All Rosiglitazone-Containing Products
27 June 2012FDA Memorandum Circular No.2012-004Adoption of PIC/S GMP Guide
03 April 2012FDA Memorandum Circular No.2012-003Full Compliance to Good Manufacturing Practice (GMP)
30 March 2012FDA Memorandum Circular No.2012-002Submission of Certificate of Analysis of Imported and Locally-Manufactured Lipsticks
06 January 2014FDA Memorandum Circular No. 2014-001Extension of Deadline to Submit Electronic Copy of All Registered Drug Products' Dossier
14 January 2014FDA Memorandum Circular No. 2014-002 New License to Operate Format for Drug Establishments
28 January 2014FDA Memorandum Circular No. 2014-003Issuance of License to Operate (LTO) with New Format for All Cosmetic and HUHS Establishments Using the FDA Security Paper
10 February 2014FDA Memorandum Circular No. 2014-004 Release of Promo and Advertisement Permits
25 February 2014FDA Memorandum Circular No. 2014-005Updated List of Medical Devices Required to be Registered Prior to Sale, Distribution and Use
03 June 2015FDA Memorandum Circular No. 2014-005-AAmendment to FDA Memorandum Circular No. 2015-005, "Updated List of Medical Devices Required to be Registered Prior to Sale, Distribution and Use"
25 March 2014FDA Memorandum Circular No. 2014-006Optional Courier Service
16 April 2014FDA Memorandum Circular No. 2014-007 Issuance of Official Receipt (OR) for Bank Payments and Full Implementation of Online Collection (OnColl) Facility of LandBank of the Philippines for Electronic Cosmetic Notification
29 April 2014FDA Memorandum Circular No. 2014-008Guidelines on the Electronic Notification of Selected Household Urban Hazardous Substance (HUHS E-Notification) System
09 May 2014FDA Memorandum Circular No. 2014-008-AAmendment to FDA Memorandum Circular 2014-008 "Guidelines on the Electronic Notification of Selected Household/Urban Hazardous Substances (HUHS E-Notification) System
04 August 2014FDA Memorandum Circular No. 2014-009Issuance of License to Operate (LTO) with a new format for all Toys and Child care articles establishments using the FDA Security Paper
03 September 2014FDA Memorandum Circular No. 2014-012Payent of FDA Academy and Seminar Fees in all branches of the Development Bank of the Philippines
01 February 2016FDA Memorandum Circular No. 2014-012-AAmendment to FDA Memorandum Circular No. 2014, " Payment of FDA Academy Training and Seminar Fees in all Branches of Development Bank of the Philippines
06 November 2014FDA Memorandum Circular No. 2014-014-AGuideline on Placement of Advertisement in All forms of Mass Social Media, Billboards and Public Transport
20 November 2014FDA Memorandum Circular No. 2014-015 Display of Antimicrobial Resistance (AMR) Infomercial
01 December 2014FDA Memorandum Circular No. 2014-016Administration of Customer Satisfaction Survey
11 December 2014FDA Memorandum Circular No. 2014-017 Correction on Annex III / PArt I Ref. No. 1a; Boric Acid, Borates and Tetraborates with the Exception of Substance No. 1184 in Annex II
27 November 2013FDA Memorandum Circular No.2013-046Payment Collection of FDA fees and charges
14 November 2013FDA Memorandum Circular No.2013-045Guidelines on Notification of Selected Household/Urban Hazardous Substance (HUHS) Products
23 October 2013FDA Memorandum Circular No.2013-044Warning on Toxic Enantiomer Levomethorphan Contaminated API Dextromethorphan Manufactured by Konduskar Laboratories Private Ltd., India
19 September 2013FDA Memorandum Circular No.2013-043Reiteration of Policies and Guidelines on Non-Appearance, Request for change of schedule or rescheduling of dates for Registered FDA Training/Seminar Participants
16 October 2013FDA Memorandum Circular No.2013-042Guidelines for Salt Manufacturers, Importers, Wholesalers, Repackers and Distributors to Ensure Adequate Iodization of Iodized Salt, and for Other Purposes
24 September 2013FDA Memorandum Circular No.2013-040Guidelines for the Exercise by the FDA of Its Power to Accept Donations
2 September 2013FDA Memorandum Circular No.2013-039Amendment of FDA Memorandum Circular No. 2013-016 dated 02 May 2013 and FDA Memorandum Circular No. 2013-024 dated 14 June 2013, "Guidelines on Electronic Registration for Training and Seminars (E-Course Registration)"
16 September 2013FDA Memorandum Circular No.2013-038Filing and Receiving of Registration and Licensing Applications
12 September 2013FDA Memorandum Circular No.2013-037Application of License to Operate and Certificate of Compliance, Among other transactions, at Center for Cosmetics Regulation and Research (CCRR) From the Center for Device Regulation, Radiation Health an Research (CDRRHR)) Starting 02 January 2014
12 September 2013FDA Memorandum Circular No.2013-036Clarification on the Features of the FDA Electronic Cosmetic Product Notification (e-Notification) System
10 September 2013FDA Memorandum Circular No.2013-035Six (6) Months Moratorium on the Requirement of Certificate of Product Registration for Raw Materials to be Presented or Submitted to the Bureau of Customs Prior to Release, as per FDA Memorandum Circular 2013-032, Dated 28 August 2013
3 September 2013FDA Memorandum Circular No.2013-034Submissions of Samples of Food Products for Registration Purposes
FDA Memorandum Circular No.2013-033-AAmendment of Procedure of Payment and Operating Hours of FDA Cashier
2 September 2013FDA Memorandum Circular No.2013-033Receiving of Applications and Payment of FDA Fees and Charges
28 August 2013FDA Memorandum Circular No.2013-032Requirements for the Immediate Release of Products Covered by the FDA at the Bureau of Customs
23 August 2013FDA Memorandum Circular No.2013-031Specific Policies on Schedule of Inspections, Including Policies on Means of Transportation and Meals
13 August 2013FDA Memorandum Circular No.2013-030Guidelines on the Use of the FDA Logo and Name in Promotional, Advertisement, Sponsorship, Marketing or Commercial Materials
22 July 2013FDA Memorandum Circular No.2013-029Fair and Equal Treatment To All FDA Clients, Consumers and Other Stakeholders
05 July 2013FDA Memorandum Circular No.2013-028General Guidelines on the Promo Permit Applications and Other Purposes
14 June 2013FDA Memorandum Circular No.2013-025Transfer of Advertisement and Promotion Functions from the Legal Services Support Center to the Other Centers of FDA
14 June 2013FDA Memorandum Circular No.2013-024Amendment to FDA Memorandum Circular No. 2013-016 "Guidelines on Electronic Registration for Training and Seminars (E-Course Registration)"
06 June 2013FDA Memorandum Circular No.2013-023Conversions to Electronic Copy of All Registered Drug Products Dossier
07 June 2013FDA Memorandum Circular No.2013-022Batch Assessment of Electronic Cosmetic Product Notification (e-Notification)
24 May 2013FDA Memorandum Circular No.2013-021Receiving of Applications (Food, Drug, Cosmetic and Household Hazardous Substances Establishments under the Regional Field Office-National Capital Region( RFO-NCR))
10 May 2013FDA Memorandum Circular No.2013-019Decking Schedule of Drug Product Registration Applications
29 April 2013FDA Memorandum Circular No.2013-018Guidelines for Payment at the Cashier Section
03 May 2013FDA Memorandum Circular No.2013-017Validation and Certification of Registered Products and License to Operate
02 May 2013FDA Memorandum Circular No.2013-016Guidelines on Electronic Registration for Training and Seminars (E-Course Registration)
30 April 2013FDA Memorandum Circular No.2013-015Guidelines for Bank Payment of Electronic Cosmetic Product Notification (E-Notification)
25 April 2013FDA Memorandum Circular No.2013-014Follow-Up of Applications
8 April 2013FDA Memorandum Circular No.2013-013Guidelines in the Conduct of the "Kapihan at Talakayan sa FDA"
8 April 2013FDA Memorandum Circular No.2013-012Revised Policies on the Application for Automatic Renewal of Certificate of Product Registration ( CPR) for Medical Devices excluding In-Vitro Diagnostic Products
21 March 2013FDA Memorandum Circular No.2013-011-AAmendment to FDA Memorandum Circular No. 2013-11 Re: Electronic Cosmetic Product Notification (E-Notification)
15 March 2013FDA Memorandum Circular No.2013-011Electronic Cosmetic Product Notification (E-Notification)
12 March 2013FDA Memorandum Circular No.2013-010Release of Hardcopy Application for License to Operate (LTO) and Certificate of Product Registration (CPR)
24 February 2013FDA Memorandum Circular No.2013-009LTO Application for Medical Devices
FDA Memorandum Circular No.2013-008List of Companies with Valid Certificate of Health Related Devices Registration (CHRDR) for their Water Purification Device/System and List of Companies with Expired CHRDR for their Water Purification Device/System
22 February 2013FDA Memorandum Circular No.2013-007Schedule of Receiving and Releasing of Food Applications
15 February 2013FDA Memorandum Circular No.2013-006-AAmendment to FDA Memorandum Circular No. 2013-006 dated 08 February 2013 entitled "Receiving of Applications"
08 February 2013FDA Memorandum Circular No.2013-006Receiving of Applications
08 February 2013FDA Memorandum Circular No.2013-005License To Operate (LTO) Data
04 February 2013FDA Memorandum Circular No.2013-004Qualified Person in Industry (Food, Drug, Cosmetic and Device ) Regulatory Affairs (QPIRA) Training-Accreditation Guidelines
22 February 2013FDA Memorandum Circular No.2013-001-AAmendment - Memorandum Circular No. 2013-001 Re: Submission of Application for License to Operate (LTO) and Certificate of Product Registration (CPR) with Electronic Copy (E-Copy)
02 January 2013FDA Memorandum Circular No.2013-001Guidelines on the Submission of LTO and CPR Application with Electronic Copy (E-Copy)

LTO and CPR App Process Flowchart
ANNEX 1 ECOMMERCE LAW
ANNEX 2 CHECKLIST FOR LTO
ANNEX 4 AFFIDAVIT
25 June 2015FDA Memorandum Circular No. 2015-008Policy and Requirements for Availing of Compassionate Special Permit for Registrable Medical Devices
17 June 2015FDA Memorandum Circular No. 2015-007Mode of Payment for Batch Notification
05 June 2015FDA Memorandum Circular No. 2015-006Release of Imported Household/Urban Hazardous Substances (HUHS) Finished Products from the Bureau of Customs (BOC) Intended Solely for Own Consumption
04 June 2015FDA Memorandum Circular No. 2015-005Reiteration to Procure Drug Products from FDA-Licensed Marketing Authorization Holders (MAH)
17 February 2015FDA Memorandum Circular No. 2015-004Revised FDA Citizen's Charter
06 February 2015FDA Memorandum Circular No. 2015-003Reiteration of the FDA Requirement for the Change in the Use of the Message/Phrase "No Approved Therapeutic Claim" in Filipino as: "Mahalagang Paalala: Ang (Name of Product) ay Hindi Gamot at Hindi Dapat Gamiting Panggamot sa Anumang Uri ng Sakit" in all Advertisements, Promotional, and/or Sponsorship Activities or Materials.
13 April 2018FDA Memorandum Circular No. 2018-001Period of Payment of e-Portal Applications
22 July 2019FDA Memorandum Circular No. 2019-005Pilot Study on the Implementation of DOH AO 2018-0002 re_ Guidelines Governing the Issuance of an Authorization for a Medical Device Based on the ASEAN Harmonized Technical Requirements
25 July 2016FDA Memorandum Circular No. 2016-004Reiterating DOH Department Memorandum No. 2016-0239 Regarding "Removal of Selected DOH IEC Materials" dated 14 July 2016
19 July 2017 FDA Memorandum Circular No. 2017-003Collection Policy and Procedure
19 July 2017 FDA Memorandum Circular No. 2017-0021st Food and Drug Administration (FDA) Regulatory Advocacy Fair and Back-to-back Qualified Person in the Industry Regulatory Affairs (QPIRA) Trainings
17 November 1986Bureau Circular No. 2 s. 1986Assignment of Brand Name and /or Generic Name for a Formulation of a Drug or Pharmaceutical Specialty
28 June 1991Bureau Circular No. 12 s. 1991Clarification of New Registration when there is a Change of Manufacturer
16 September 1994Bureau Circular No. 23 s. 1994Amending Memo Circular No. 4 s. 1994: Compliance with IRR of Senior Citizen Act
18 November 1994Bureau Circular No. 2 s. 1994Amendment of MC No. 4 s. 1994
17 October 1995Bureau Circular No. 4 s. 1995Period within an Initial Conditional Registration shall be Processed and Issued
9 October 1995Bureau Circular No. 3-A s. 1995Revised and /or Updated Lists of Ingredients or Substances in Cosmetics Recommended after a Series of Review and Studies by the BFAD-Industry Joint Study Group
16 February 1995Bureau Circular No. 1 s. 1995Phase-out of Potassium Bromate as Flour Treatment in Bread-Making
14 May 1998Bureau Circular No. 03 s. 1998Upgrading of Manufacturing Facilities in Consonance with CGMP Requirements Beginning 1996 Up to Year-End 1999
3 August 1998Bureau Circular No. 05 s. 1998Extension of the Validity Period of Renewal Registration of Medical and Dental Devices
23 October 1998Bureau Circular No. 07 s. 1998Adoption of the Guiding Principles for Good Manufacturing Practice (GMP) Guidelines in the Manufacture of Cosmetic Products
13 April 1999Bureau Circular No. 08 s. 1998Upgrading of Manufacturing Facilities in Consonance with CGMP Requirements Beginning 1996 Up to Year-End 1999
07 August 1996Bureau Circular No. 05 s. 1996Iterating Article IV, Section 25 of Republic Act 5921
30 July 1996Bureau Circular No. 04 s. 1996Pertinent Provisions of Republic Act (RA) 7581 otherwise Known as the Price Act
22 April 1996Bureau Circular No. 03 s. 1996Selling of Drugs or Medicines to the Public
11 April 1996Bureau Circular No. 02 s. 1996Ban Against Importation of UK Beef and Beef Products Effective Immediately
05 September 1997Bureau Circular No. 13 s. 1997The Advertising and Promotions Agencies Manufacturers and Distributors of Processed Food, Drugs, Devices, Cosmetics, and Household Hazardous Substances, other Parties Concerned
04 September 1997Bureau Circular No. 12 s. 19971997 Updated Listing of Cosmetic Ingredients
02 September 1997Bureau Circular No. 11 s. 1997Extension of the Period to Declare Unregistered Imported Food Products Under Bureau Circular No. 4 s. 1997
10 July 0199Bureau Circular No. 09 s. 1997Specific Guidelines for Preparation of Order of Payment and Collection of Fees for Certificate of Authentication for Copies of BFAD Official Document(s)
30 April 1997Bureau Circular No. 08 s. 1997Implementation Details of BFAD Circular No. 1 s. 1997
31 March 1997Bureau Circular No. 06 s. 1997Extension of the Period to Declare Unregistered Imported Food Products Under Bureau Circular No. 4 s. 1997
19 March 1997Bureau Circular No. 05 s. 1997Revised Checklist of Requirements and the 1997 Guidelines for the Registration of Pharmaceutical Products
03 February 1997Bureau Circular No. 03 s. 1997Guidelines for the Processing of Requests for Authentication for Copies of BFAD Official Documents by Parties other than the Department of Health or any of its Agencies
04 February 1997Bureau Circular No. 02 s. 1997Accreditation of Drug Liaison Officers
21 January 1997Bureau Circular No. 1 s. 1997For Registration of Products Included in the List B' (Prime) Under DOH-Administrative Order No. 67 Series of 1989
18 January 2002Bureau Circular No. 01 s. 2002Notarized Application Forms for Product Registration
22 January 2002Bureau Circular No. 02 s. 2002Setting the Deadline for the Compliance with Bureau Circular No. 16-A s. 2001 on the Labelling and Advertisement of Cigarettes
31 January 2002Bureau Circular No. 03 s. 2002Reclassification of Sambong 250 mg Tablet from Over-The-Counter (OTC) to Household Remedy
04 April 2002Bureau Circular No. 05 s. 2002Extension of the Validity Period of Initial and Renewal Registration of In-vitro Diagnostic Reagents/Kits
04 April 2002Bureau Circular No. 06 s. 2002Amending Bureau Circular No. 02 s. 2002 setting the Deadline for Compliance on the Labeling and Advertisement of Cigarettes Mandated under DOH-Administrative Order No. 10 s. 1993 and Bureau Circular No. 16-A s. 2001
29 April 2002Bureau Circular No. 07 s. 2002Upgrading of Manufacturing Facilities in Harmony with AO No. 90 s. 2002, Current Good Manufacturing Practice (cGMP) Guidelines for Cosmetic Products
25 October 2002Bureau Circular No. 08 s. 2002Guidelines for Monitoring Iodized Salt
15 August 2002Bureau Circular No. 09 s. 2002Customs Memorandum Circular No. 218-2000 Dated 18 July 2002
11 September 2002Bureau Circular No. 10 s. 2002Revised List of Permissible Cosmetics Claims that Require Justification
03 October 2002Bureau Circular No. 11 s. 2002Site Information File (SIF)
25 October 2002Bureau Circular No. 12 s. 2002Reiterating the Ban on the Use of Chloramphenicol in Food Producing Animals
25 October 2002Bureau Circular No. 13 s. 2002The Field Test Kits for Iodated Salt
24 November 1999Bureau Circular No. 23 s. 1999Exfoliant and Exfoliate as Permissible Claims for Cosmetic Preparations
27 October 1999Bureau Circular No. 22 s. 1999Deletion of the Requirement for a Certificate of Brand Name Clearance in Filing an Application for Registration of Branded Products
27 October 1999Bureau Circular No. 21 s. 1999Guidelines for the Evaluation of Brand Names for Products to be Registered with the Bureau of Food and Drugs
Bureau Circular No. 19 s. 1999Re-Iterating Section 20(b)(1)(B) of RA 3720 as Amended by Section 12 of EO 175 and Section 29-a of EO 175
16 August 1999Bureau Circular No. 18 s. 1999Importation and Registration of Imported Pre-Packed Food Products
23 July 1999Bureau Circular No. 17-A s. 1999Resumption of Acceptance of Application for Registration of Branded Ethical/Prescription Pharmaceutical Products
23 July 1999Bureau Circular No. 17 s. 1999Transfer of Processing of Brand Name Clearance for Pharmaceutical Products to the Intellectual Property Office (IPO)
06 January 1999Bureau Circular No. 16 s. 1999Amending BFAD MC #22 Dated September 8, 1994 Regarding Inventory, Proper Disposal and/or Destruction of Used Vials or Bottles
14 June 1999Bureau Circular No. 13-A s. 1999Moratorium on the Conduct of Bioavailability/Bioequivalence Studies for Pharmaceutical Products
11 June 1999Bureau Circular No. 12-B s. 1999Phasing-Out the Registration of Branded Version of Registered Unbranded Drug Product and Unbranded Version of Registered Branded Drug Product (Memorandum Circular No. 10-A s. 1992)
01 June 1999Bureau Circular No. 11 s. 1999Certification of Registrations' Annotation of Suspension/Cancellation of Drug or Drug Product Combination Found to be Adulterated/Misbranded
22 April 1999Bureau Circular No. 9 s. 1999Labeling of Prepackaged Processed Meat Products
Bureau Circular No. 8-A s. 1999Guidelines in the Collection and Submission of Samples of Food, Drugs, Cosmetics, and Medical Devices for Physico-Chemical Analysis
13 April 1999Bureau Circular No. 8s. 1999Amendment to Bureau Circular No. 8 s. 1998 Registration of Imported Food Products Covered by an Exclusive Distributorship Agreement; and Sale or Offer for Sale of the same Products whose Registration Papers are still In-Process
18 February 1999Bureau Circular No. 7 s. 1999Re-Iterating Article IV, Section 30 of Republic Act 5921
15 February 1999Bureau Circular No. 6 s. 1999Revised Bureau Circular No. 4 s. 1999 New Protocol for Registration of Drugs, Foods, Cosmetics and Medical Devices
10 February 1999Bureau Circular No. 05 s. 1999Revised Process of Submission of Application for Product Registration
14 June 2000Bureau Circular No. 4 s. 2000Implementation of Administrative Order No. 13, s. 1999, "Use of Hydroquinone and/or Tretinoin (Retinoic Acid)
08 June 2000Bureau Circular No. 3-A s. 2000Amendment to FDA Circular No. 2 s. of 1982 on the Importation of Semi-Synthetic Antibiotics
28 February 2000Bureau Circular No. 3 s. 2000Submission of Test Procedures and Test Specifications for Products to be Included in the Philippine Pharmacopeia
24 January 2000Bureau Circular No. 2 s. 2000Submission of List of All Pending Applications for Registration/Listing of Cosmetic Products and Household Hazardous Substances
13 January 2000Bureau Circular No. 1 s. 2000Moratorium on the Acceptance of Application for Initial Registration of Pharmaceutical Products
7 December 2001Bureau Circular No. 18 s. 2001Delisting of Levonorgestrel 750 mcg (Postinor) from Bureau of Food and Drugs Registry of Drug Products
21 November 2001Bureau Circular No. 17 s. 2001In answer to queries on the classification of the products listed below, the Office of the Director issues this Bureau Circular for all those concerned. Please be advised that the classification of the following products
20 November 2001Bureau Circular No. 16-A s. 2001Labelling and Advertisement of Cigarettes
20 November 2001Bureau Circular No. 16 s. 2001Guidelines for the Immediate Processing of Applications for Initial Registration of Pharmaceutical Products
November 13, 2001Bureau Circular No. 15-A s. 2001Amendment to BFAD Circular No. 23 Dated 16 September 1994
October 26, 2001Bureau Circular No. 15 s. 2001Guidelines for the Immediate Processing of Pending Applications for Renewal Registration of Pharmaceutical Products
October 26, 2001Bureau Circular No. 14 s. 2001Amendment to Bureau Circular No. 13-A s. 2001 "Over-the-Counter (OTC) Drugs Reclassified as Household Remedies"
October 17, 2001Bureau Circular No. 13-A s. 2001Amendment to Bureau Circular No. 11 s. 2001 "Over-the-Counter (OTC) Drugs Reclassified as Household Remedies"
October 17, 2001Bureau Circular No. 13 s. 2001Erratum to Bureau Circular No. 9 s. 2001
October 5, 2001Bureau Circular No. 12 s. 2001Addendum to Bureau Circular No. 6-A s. 2001 Dated June 11, 2001
August 20, 2001Bureau Circular No. 11 s. 2001Over-the-Counter (OTC) Drugs Reclassified as Household Remedies
August 10, 2001Bureau Circular No. 10 s. 2001Submission of Site Information File and Updating
August 7, 2001Bureau Circular No. 09 s. 2001Glass Ionomers of Atraumatic Restorative Treatment (ART), Fit and Fissure Sealant, Hand Instruments with Kits for ART
6 July 2001Bureau Circular No. 08 s. 2001Guidelines to be Observed on the Implementation of Product Recall System
22 June 2001Bureau Circular No. 07 s. 2001Proposed Guidelines for the Assessment of Microbiological Quality of Processed Foods
11 June 2001Bureau Circular No. 06-A s. 2001Revised Minimum Required Samples for Laboratory Analysis
30 May 2001Bureau Circular No. 06 s. 2001Aflatoxin M1 in Milk
30 May 2001Bureau Circular No. 05 s. 2001Acute Toxicity of Tin
20 April 2001Bureau Circular No. 04 s. 2001Extension of the Validity of Monitored Release Study
5 April 2001Bureau Circular No. 03 s. 2001Cancellation of the Certificates of Product Registration, Seizure and Confiscation of BFAD registered products, which do not conform to their registered specifications
8 March 2001Bureau Circular No. 02 s. 2001Advisory on Voluntary Recall of Processed Meat Products Imported from European Countries
8 March 2001Bureau Circular No. 01 s. 2001Guidelines on the Temporary Ban on the Importation of Processed Meat Products from Cattle, Sheep and Goat, and other Food Ingredients Containing Substances Derived from these Animals
10 April 2003Bureau Circular No. 05-B s. 2003Attendance in Licensing Seminar as a Requirement in the Application for a License to Operate of a Drug Establishment / Drug Outlet (AO 56 s. 1989)
10 April 2003Bureau Circular No. 05 s. 2003Classification of Hemodialysis Products as Drugs
17 March 2003Bureau Circular No. 03-A s. 2003Mandatory Dissemination of Information Regarding the Precaution/Warning of Drug Products Containing Phenylpropanolamine (PPA)
17 March 2003Bureau Circular No. 03 s. 2003Mandatory Printing of Boxed Warning on All Phenylpropanolamine (PPA) Containing Products (OTC and RX)
13 February 2003Bureau Circular No. 02 s. 2003Classification of Paracetamol Syrup/Suspension 120 mg/5mL and 125 mg/5mL
04 January 2005Bureau Circular No. 01 s. 2005Classification of All Injectable Hyaluronic Acid as Device
19 January 2005Bureau Circular No. 03s. 2005Submission of Site Information File
03 January 2005Bureau Circular No. 05 s. 2005Black Box Warning for all Antidepressant Drugs
10 February 2005Bureau Circular No. 06 s. 2005List of Recognized Laboratories
04 April 2005Bureau Circular No. 08 s. 2005Selective COX-2 Inhibitors
07 April 2005Bureau Circular No. 09 s. 2005Submission of Site Information File
07 June 2005Bureau Circular No. 11 s. 2005Revised Labeling of Selective COX-2 Inhibitor Drugs and NSAIDS
22 June 2005Bureau Circular No. 12 s. 2005BFAD Quality Seal
22 June 2004Bureau Circular No. 13 s. 2005Submission of Site Information File (SIF)
29 June 2005Bureau Circular No. 13-A s. 2005Reconstitution of the BFAD-Cosmetics Industry Joint Committee
06 July 2005Bureau Circular No. 14 s. 2005Gene Therapy
14 July 2005Bureau Circular No. 18 s. 2005New Advisory on Labeling Selective Cycloxygenase-2 (COX-2) Inhibitors and Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
21 October 2005Bureau Circular No. 19 s. 2005 Extension of Submission of Site Information File (SIF)
24 October 2005Bureau Circular No. 20 s. 2005Revised Assessment Slips
11 November 2005Bureau Circular No. 21 s. 2005Cut-Off Time for the Receiving of Payments of Fees in BFAD
13 December 2004Bureau Circular No. 20 s. 2004Submission of Application for Registration in Accordance with the Asean Common Technical Document (ACTD) Format
26 November 2004Bureau Circular No. 19 s. 2004Delisting of Rofecoxib from Bureau of Food and Drugs Registry of Drug Products
17 November 2004Bureau Circular No. 18 s. 2004Mandating the Use of Vitamin A and Iron Fortified Flour
12 October 2004Bureau Circular No. 14 s. 2004Submission of Adverse Drug Reaction Reports on COX-2 Inhibitors as Part of Safety Monitoring
27 September 2004Bureau Circular No. 13 s. 2004Clarification of Par. a, Bureau Circular No. 6 s. 1999 (Revised BC No. 4 s. 1999 "New Protocol for Registration of Drugs, Foods, Cosmetics and Medical Devices")
14 September 2004Bureau Circular No. 12 s. 2004Entry of Meat-Based Food Products into the EU
2 August 2004Bureau Circular No. 11 s. 2004Food and Drugs (Composition and Labeling Amendment) Regulation 2004 Issued by Hongkong Food and Environmental Hygiene Department
27 July 2004Bureau Circular No. 10 s. 2004Information on the Exportation of Fresh/Frozen Marine Products and Fresh, Frozen and Chilled Chicken Meat from the Philippines
1 July 2004Bureau Circular No. 09 s. 2004Articles Regarding the Bioterrorism Act Published/Released by the US Food and Drug Administration
10 June 2004Bureau Circular No. 08 s. 2004Regulation and Monitoring of the Mandatory Fortification of Staples (Rice, Sugar, Flour and Cooking Oil) and their Utilization by Food Processors as Ingredients
3 June 2004Bureau Circular No. 07 s. 2004Registration of Veterinary Products
18 May 2004Bureau Circular No. 06 s. 2004Office of the President Memorandum Order No. 136: Approving the 2004 Investment Priorities Plan
06 April 2004Bureau Circular No. 05 s. 2004Consolidation and Updates of Permissible Cosmetic Claims
3 April 2004Bureau Circular No. 04-B s. 2004Whitening Agents in Cosmetics Preparations
30 March 2004Bureau Circular No. 04-A s. 2004Different Brand names for narcotic/Opioid Analgesic Drugs for Cancer Pain
30 March 2004Bureau Circular No. 04 s. 2004Reiterating Memorandum Circular No. 008 s. 1988 (Re: Drug and Medical Device Registration)
26 March 2004Bureau Circular No. 03 s. 2004Guidelines for the Registration and Performance Validation of Methamphetamine (MET)/Tetrahydrocannabinol (THC) Drug Screening Test Kits
04 February 2004Bureau Circular No. 01-A s. 2004Guidelines for the Assessment of Microbiological Quality of Processed Foods
08 January 2004Bureau Circular No. 01 s. 2004Sale of BFAD: ICR Mice and BFAD: SD Rat
18 December 2006Bureau Circular No. 2006-017Amendment to Bureau Circular 2006-001 Updated Guidelines for the Submission of Application for Notification, Registration and Export of Cosmetic Products
18 October 2006Bureau Circular No. 2006-015Guidelines for the Issuance of a Conditional Certificate of Product Registration for Veterinary Products with Initial Registration with the Bureau of Food and Drugs
04 October 2006Bureau Circular No. 2006-014Licensing of Veterinary Establishments
05 September 2006Bureau Circular No. 2006-013Amendment to Bureau Circular No. 17 s. 2005 further Updating the Accepted Whitening Agents for Cosmetics
04 September 2006Bureau Circular No. 2006-012Maximum Allowable Limits of Heavy Metals for Cosmetic Products
19 June 2006Bureau Circular No. 10 s. 2006 Good Manufacturing Practice Seminar for Food Establishments Based on AO 153 s. 2004 and Other Related Regulations
22 May 2006Bureau Circular No. 09 s. 2006 Amendment to Bureau Circular No. 06. s. 2005 - List of Recognized Laboratories
08 October 2007Bureau Circular No. 2006-008-A Amendment to Bureau Circular No. 008 s. 2006, The Subject of which is the Lifting of Moratorium on the Conduct of Bioavailability/Bioequivalence Studies for Selected Pharmaceutical Products and Bureau Circular No. 2007-005 or the Supplemental Guidelines for the Processing of Principal Certificate of Product Registration and Providing for the Procedures and/or Guidelines thereof
27 April 2006Bureau Circular No. 08 s. 2006 Lifting of Moratorium on the Conduct of Bioavailability / Bioequivalence Studies for Selected Pharmaceutical Products
28 February 2006Bureau Circular No. 06 s. 2006 Creation of BFAD Food Fortification Data Management System Team
22 February 2006Bureau Circular No. 05 s. 2006 Guidelines for the Submission of Application for Automatic Renewal Registration of Pharmaceutical Products, Medical Devices , Prepackaged Food and Food Products, and Household Hazardous Substances
28 February 2006Bureau Circular No. 04 s. 2006 Mandatory Fortification of Flour
10 February 2006Bureau Circular No. 03 s. 2006 Mandatory Attendance to the Cosmetic Seminar Covering the 13 ASEAN Training Modules on Good Manufacturing Practice
09 February 2006Bureau Circular No. 02 s. 2006 Implementation of Bureau of Food and Drugs Quality Seal Program in Line with the FOURmula One for Health Initiative
03 January 2006Bureau Circular No. 01 s. 2006 Updated Guidelines for the Submission of Application for Notification, Registration and Export of Cosmetic Products
29 January 2007Bureau Circular No. 2007-001 Mandatory Submission of List Products Being Handled
27 February 2007Bureau Circular No. 2007-004Guidelines for the Implementation of Administrative Order No. 2007-006 (Amendment to Administrative Order No. 46 s. 1988 Re: Organizational Arrangements to Implement the National Drug Policy)
2 April 2007Bureau Circular No. 2007-005Supplemental Guidelines for the Processing of Principal Certificate of Product Registration (CPR)
12 July 2007Bureau Circular No. 2007-006Additional Requirement for Importation of Processed Food Products for Distribution in the Philippines
24 March 2008Bureau Circular No. 2007-006-AAmendment to Bureau Circular No. 2007-006 Providing for the Additional Requirement for Importation of Processed Food Products for Distribution in the Philippines
27 July 2007Bureau Circular No. 2007-007Products Imported from China
10 October 2007Bureau Circular No. 2007-009Updated Standards for Iodine Level of Salts
10 October 2007Bureau Circular No. 2007-009Updated Standards for Iodine Level of Salts
1 October 2007Bureau Circular No. 2007-011Adoption of the Association of Southeast Asian Nations Common Technical Documents (ACTD) and Common Technical Requirements (ACTR) on the Pharmaceutical Product Registration for Human Use
21 December 2007Bureau Circular No. 2007-013Updated Guidelines for the Implementation of the Association of South East Asian Nation (ASEAN) Cosmetic Directive and the Association of South East Asian Nation (ASEAN) Common Technical Documents
21 January 2008Bureau Circular No. 2007-013-AAmendment to Bureau Circular No. 2007-013 Updated Guidelines for the Implementation of the Association of South East Asian Nation (ASEAN) Cosmetic Directive and the Association of South East Asian Nation (ASEAN) Common Technical Documents
08 January 2020Administrative Order No. 2020-0001Guidelines in the Importation, Facilitation and Management of Foreign Donations involving Health and Health-Related Products
09 December 2008Bureau Circular No. 2008-005Grace Period for the 3rd Updates and Amendments of the ASEAN Cosmetic Directive (ACD)
29 September 2008Bureau Circular No. 2008-004Testing of Infant Formula and Other Milk Product for the Presence of Melamine

Partial List of Milk and Other Milk Products Collected by BFAD for Testing for the Presence of Melamine

Updated Partial List of Milk and Other Milk Products Collected by BFAD for Testing for the Presence of Melamine as of 29 September 2008
07 August 2008Bureau Circular No. 2008-003Grace Period for the 2nd Updates and Amendments of the ASEAN Cosmetic Directive (ACD)
10 June 2008Bureau Circular No. 2008-002Seminar Fees for the Participants of Seminars on Licensing of Establishments and Product Registration
02 May 2008Bureau Circular No. 2008-001Grace Period for the New Updates and Amendments of the ASEAN Cosmetic Directive (ACD)
15 August 2010FDA Circular No.2010-018New Price of ASEAN Reference Substances (ARS)
04 October 2010FDA Circular No.2010-017Uploading of All Data for the Electronic Essential Drug Price Monitoring System (e-EDPMS)
15 October 2010FDA Circular No.2010-016-AAmending FDA Circular No. 2010-016 Dated 20 September 2010 by Declaring Additional Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize from Public Sale and Distribution such P
20 September 2010FDA Circular No.2010-016Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous
21 August 2010FDA Circular No.2010-015Declaring the Identified Products to be Imminently Injurious Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Product from Public Sale or Distribution
12 August 2010FDA Circular No.2010-014Updates and Amendments of ASEAN Cosmetic Directive (ACD)
02 August 2010FDA Circular No.2010-013Revised Notification Template for Cosmetic Products
08 July 2010FDA Circular No.2010-012Republic Act No. 9442 and Its Implementing Rules and Regulations
16 June 2010FDA Circular No.2010-011Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
2 April 2012FDA Circular No.2010-010-AAmendment to FDA Circular No. 2010 Dated 24 May 2010 Cut-Off Time for Receiving of Applications and Payment of Fees in FDA
24 May 2010FDA Circular No.2010-010Cut-Off Time for Receiving of Applications and Payments of Fees in FDA
16 April 2010FDA Circular No.2010-009Amendment to Memorandum Circular No. 5 s. 1994 Dated April 20, 1994 Regarding Report on Adverse Drug Reaction
29 March 2010FDA Circular No.2010-008Adoption of the CODEX Standards on Food Contaminants in Processed Food
15 March 2010FDA Circular No.2010-007Automatic Renewal of License to Operate (LTO)
09 March 2010FDA Circular No.2010-006Automatic Revalidation of License to Operate (LTO)
17 February 2010FDA Circular No.2010-005Submission of Process Flow in Handling Adverse Events from Drugs, Medical Devices, Food Supplements, Milk Products, Herbals, etc.
18 February 2010FDA Circular No.2010-004Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
20 January 2010FDA Circular No.2010-003Revised Fees for Seminar on Licensing of Drug Establishments
08 January 2010FDA Circular No.2010-002Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
08 January 2010FDA Circular No.2010-001Declaring the Products Identified Below to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
19 January 2009Bureau Circular No. 2009-002Specific Operational Instructions Implementing Administrative Order No. 2008-0033 Dated December 2, 2008, Subject: Rules and Conditions in Exempting Antibiotic Drug Products from the Batch Certification Requirement Amending for this Purpose Item III (C) and (D) of Administrative Order No. 103 s. 2002 "Batch Certification of Antibiotics", and for Other Purposes.
02 July 2009Bureau Circular No. 2009-003Grace Period for the 4th Updates and Amendments of the ASEAN Cosmetic Directive (ACD)
Bureau Circular No. 2009-004End Dates in the Importation and Distribution of Metered Dose Inhalers Containing Chlorofluorocarbon (CFC)
08 February 2012FDA Circular No. 2012-001New Pharmacist Form
15 February 2012FDA Circular No. 2012-002Dishonored Checks
21 February 2012FDA Circular No. 2012-003Declaring Unregistered Slimming Products to be Imminently Injurious, Unsafe or Dangerous and Ordering the Recall, Ban or Seizure from Public Sale or Distribution
20 April 2012FDA Circular No. 2012-004Express Lane for Payment of FDA Fees and Charges
02 June 2012FDA Circular No. 2012-007Recognition of Ethical Review Board/Committee (ERB/ERC) for Purposes of the Conduct of Clinical Trials on Investigational Medicinal Products in the Philippines and for Other Purposes
24 May 2019FDA Circular No. 2012-007-AReduction of Turn-Around-Time for the Regulatory Review of Clinical Trials and Revised Procedure for the Application of Import License for Investigational Products
30 July 2012FDA Circular No. 2012-008Licensing and Registration Seminar for Food Establishments
03 September 2012FDA Circular No. 2012-009Declaring the Below Identified Additional Cosmetic Products to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize the Products Listed Therein from Public Sale or Distribution
05 September 2012FDA Circular No. 2012-011Authority of FDA Inspectors
05 September 2012FDA Circular No. 2012-012Guidelines for Handling Rapid Alerts Arising from Quality Defects
16 August 2012FDA Circular No. 2012-014Disposition of Flood-Affected Health Products
7 July 2011FDA Circular No. 2011-003-ARevision to the Schedule of Fees Listed in FDA Circular No. 2011-003 Dated 24 June 2011 on the Collection of Legal Research Fee Imposed by Republic Act No. 3870, as Amended by PD 200 and Further by PD 1856
24 June 2011FDA Circular No. 2011-003Collection of Legal Research Fee Imposed by Republic Act No. 3870, as Amended by PD 200 and Further Amended by PD 1856
02 June 2011FDA Circular No. 2011-002Application for Revision/Updates in the Package Insert, Patient Leaflet Information, Prescribing Information, Core Date Sheet and Basic Succinct Statement
02 May 2011FDA Circular No. 2011-001Declaring Unregistered Contact Lenses to be Imminently Injurious, Unsafe or Dangerous and Authorizing the FDA Inspectors to Seize Said Products from Public Sale or Distribution
05 September 2013FDA Circular No. 2013-024Adoption and Implementation of "The Mexico City Principles for Vocabulary Codes of Business Ethics in the Biopharmaceutical Sectors"

The Mexico City Principles
23 August 2013FDA Circular No. 2013-022Guidelines on Handling Consumer Complaints
15 August 2013FDA Circular No. 2013-021Comparator Drugs for Selected Pharmaceutical Products Containing Biopharmaceutics Classification System (BCS) Class 4 Drug Molecules
13 April 2013FDA Circular No. 2013-020Reiteration of Registration of Human Cells, Tissues, and Cellular and Tissue-Based Products
08 July 2013FDA Circular No. 2013-017Registration of Human Stem Cell-Based Products
20 June 2013FDA Circular No. 2013-015Deregulation of Bulk Industrial Chemicals Used as Raw Materials in Cosmetic Products and Household Products Considered as Urban Hazardous Substances
FDA Circular No. 2013-014List of Product Requiring Bioequivalence (BE) Studies as Part of the Application for Marketing Authorization in Addition to Rifampicin and the 11 Products Listed in Bureau Circular No. 2006-008
02 May 2013FDA Circular No. 2013-013Registration Amnesty for Non-Compliant Products Specifically Under Product Classification, Category IV- Do-It-Yourself and Hobby Products, Classified as Household/Urban Hazardous Substances (HUHS)
15 April 2013FDA Circular No. 2013-012Validity of Generic Labeling Exemption for Pharmaceutical Products
27 March 2013FDA Circular No. 2013-011Updates and Amendments of ASEAN Cosmetic Directive (ACD)

Annex II revised as per 17th ACSB

Annex III part 1revised as per 17th ACSB-1

Annex VI revised as per 17th ACSB

Annex VII revised as per 17th ACSB
16 June 2014FDA Circular No. 2013-009-AAmendment to FDA Circular No. 2013-009 "Revised Guidelines in Licensing of Household Hazardous Substances (HHS) Establishments"

"CHECKLIST OF REQUIREMENTS FOR THE ISSUANCE OF LICENSE TOOPERATE FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS)ESTABLISHMENTS"

Petition Form-HHS 2013 FINAL
06 March 2013FDA Circular No. 2013-009Revised Guidelines in Licensing Household Hazardous Substances (HHS) Establishments
06 March 2015FDA Circular No. 2013-008-AAmendment to FDA Circular No. 2013-008 on A. Process and Communication under Section IV. Details / Directive
22 April 2013FDA Circular No. 2013-008Adoption of the Association of the Southeast Asian Nations (ASEAN) Post-Marketing Alert System (PMAS) for Defective or Unsafe Processed Food Products, Pharmaceutical Products, Traditional Medicines and Health Supplements, and Cosmetic and Household Hazardous Products and Devices
05 March 2013FDA Circular No. 2013-007Amendment of Bureau Circular No. 2007-009 on the Standard Iodine Level of Salts for Strict Compliance of Iodized Salt Manufacturers or Processors
20 March 2013FDA Circular No. 2013-006-AAmendment to FDA Circular No. 2013-006 Dated 28 February 2013, "Bureau of Customs Cargo Import or Export Permits and Clearance in Electronic Form Requirement through the Philippines National Single Window"
28 February 2013FDA Circular No. 2013-006Bureau of Customs Cargo Import or Export Permits and Clearance in Electronic Form Requirement Through the Philippine National Single Window
19 February 2013FDA Circular No. 2013-005Training Courses and Schedule of Fees for the Training Offered by the FDA Academy - Policy Planning Office for Calendar Year 2013
22 February 2013FDA Circular No. 2013-004Post Market Surveillance (PMS) of Authorized Drug Products
16 June 2014FDA Circular No. 2013-002-A Amendment to FDA Circular No. 2013-002 "Revised Guidelines in Licensing of Cosmetic Establishments"

CHECKLIST OF REQUIREMENTS FOR THE ISSUANCE OF LICENSE TO OPERATE FOR COSMETIC ESTABLISHMENTS

Joint Affidavit of Undertaking-COSMETICS 2013

Petition Form-COSMETICS 2013 FINAL

EXPLANATORY NOTES FOR INDUSTRY ON THE PREPARATION OF A SITE INFORMATION FILE
04 February 2013FDA Circular No. 2013-002Revised Guidelines in Licensing Cosmetic Establishments
31 January 2013FDA Circular No. 2013-001-A Amendment of FDA Circular No. 2013-001
09 January 2014FDA Circular No. 2014-001Training Courses and Schedule of Fees for the Trainings Offered by The FDA Academy - Policy Planning Office for Calendar Year 2014
14 January 2014FDA Circular No. 2014-002New License to Operate Format for Drug Establishments
11 February 2014FDA Circular No. 2014-003 Filing and Receiving of Registration, Licensing and Other Applications Using the Integrated Application Form
19 February 2014FDA Circular No. 2014-004Extension of Six-Month Moratorium on the Requirement of Certificate of Product Registration for Raw Materials to be Presented to the Bureau of Customs (BOC) Prior to Release per FDA Memorandum Circular (FMC) No. 2013-032 And FMC No. 2013-035 Until 31 August 2014
24 February 2014FDA Circular No. 2014-006Application for LTO Variation
22 June 2016FDA Circular No. 2014-008-AAmendment to Annex B, Notification for Minor of FDA Circular No. 2014-008 entitled "Application Process and Requirements for Post-Approval Changes of Pharmaceutical Products", Specially on Section IV, C, D, and E for Minor variation-Notification
29 April 2014FDA Circular No. 2014-011Adoption of Unique Global Product Identification Number
14 April 2014FDA Circular No. 2014-012Requiring Proof of Courier Service Payment for Promotion and Advertisement Permits
FDA Circular No. 2014-015 Manufacture, Sale and Distribution of Traditional and Alternative Medicines
30 May 2014FDA Circular No. 2014-016Implementing Guidelines for Administrative Order No. 2013-0022 dated 13 August 2013, Subject: Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers
21 July 2014FDA Circular No. 2014-017Procedure in the submission and issuance of the Food and Drug Administration Certification for Animal Feeds and Feed Products
15 August 2014FDA Circular No. 2014-018Manufacture, Sale and Distribution of Unregistered Medical Grade Oxygen
23 October 2014FDA Circular No. 2014-018-AAmendment to FDA Circular No. 2014-018 Dated 15 August 2014 Entitled Manufacture, Sale, and Distribution of Medical-Grade Oxygen
18 August 2014FDA Circular No. 2014-019 Moratorium on the Imposition of Penalty Fess During Renewal of LTO as Food, Drugs, Medical Devices or Cosmetic Manufacturer or Distributor
01 September 2014FDA Circular No. 2014-020Submission of Compliances to Notice of Deficiencies (NODs) Relative to Registration Applications and Corrective Action / Preventive Action (CAPA) Plan based on Inspection Findings
16 September 2014FDA Circular No. 2014-021Transition period for the Implementation of AO 2014-0029 and Application Holiday for Certificate of Product Registration for Raw Materials Superseding FDA Memorandum Circular (FMC) No. 2013-032, FMC No. 2013-035
22 September 2014FDA Circular No. 2014-022Notification of Registered Imported Wines with New Vintage
26 September 2014FDA Circular No. 2014-023Guideline on the Manual Notification of Toys and Childcare Articles (CCA's)
16 October 2014FDA Circular No. 2014-023-AAddendum to FDA Circular No. 2014-023 Dated 26 September 2014 Subject : Guidelines on the Manual Notification of Toys and Childcare Articles
30 September 2014FDA Circular No. 2014-024 Rules and Regulations on Securing FDA Authorization for Food and Cosmetic Micro Enterprises and their Products in Collaboration with Department of Trade and Industry (DTI) Negosyo Centers and Local Government Units (LGU's)
21 November 2014FDA Circular No. 2014-025Guideline on Implementation of New Rules and Regulation on Licensing of Drugstore / Pharmacy / Botica and Similar Outlets following Administrative Order No. 2014-0034, dated 13 October 2014
21 November 2014FDA Circular No. 2014-026Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Distributors following Administrative Order No. 2014-0034, dated 13 October 2014
21 November 2014FDA Circular No. 2014-027Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Manufacturer following Administrative Order No. 2014-0034, dated 13 October 2014
21 November 2014FDA Circular No. 2014-028 Guideline on the Implementation of New Rules and Regulation on Licensing of Retail Outlet for Non-Prescription Drugs (RONPD's) following Administrative Order No. 2014-0034, dated 13 October 2014
28 November 2014FDA Circular No. 2014-029Procedure for the Use of Electronic Registration (E-Registration) System for Raw Materials or Ingredients and Low Risk Pre-Packaged Processed Food Products
14 April 2015FDA Circular No. 2015-008Updates and Amendments of ASEAN Cosmetic Directive (ACD)
10 April 2015FDA Circular No. 2015-007Rules and Regulation on the Licensing of Hospitals and Other health facilities Involved in the Manufacture of Medical Gases
13 April 2015FDA Circular No. 2015-006New LTO Format for Drug Establishments following Administrative Order No. 2014-0034
09 February 2015FDA Circular No. 2015-001-AAmendment to FDA Circular No. 001, Clarification on the Regulations Governing Principal and Identical Drug Products as defined under Administrative Order No. 2005-0031
24 September 2019FDA Circular 2019-006GUIDELINES IN COMMERCIAL DISPLAY, SELLING, PROMOTION, AND ADVERTISING OF ALCOHOLIC BEVERAGES AND BEVERAGES THAT CONTAIN ALCOHOL
16 September 2019FDA Circular 2019-005Updates and Amendments of the ASEAN Cosmetic Directive (ACD) as Adopted During the 30th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings
11 February 2019FDA Circular 2019-002

Updates and Amendments of the ASEAN Cosmetic Directive (ACD) as Adopted During the 29th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings


FDA Circular - 29th ACC Annex A

FDA Circular - 29th ACC Annex B

FDA Circular - 29th ACC Annex C
4 February 2019FDA Circular 2019-001Training Course/Seminars and Schedule of Fees for the Trainings Offered by the Food and Drug Administration (FDA) Academy - Policy and Planning Service (PPS) for Calendar Year 2019
13 August 2013Administrative Order No. 2013-0022Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers
23 January 2019FDA Circular No. 2018-011-AAmendment of FDA Circular No. 2018-011 "Schedule of Unified Licensing Seminar for Calendar Year 2018
20 August 2018FDA Circular No. 2018-010Amendment to BFAD Memorandum entitled "Guidelines for the Transshipment of Salt" dated 02 October 2004 and repeal of FDA Memorandum No. 2013-050 dated 25 July 2013
9 July 2018FDA Circular No. 2018-009Updates and Amendments of the ASEAN Cosmetic Directives (ACD) as Adopted During the 28th ASEAN Cosmetic Committee (ACC) Meetings and Its Related Meetings
29 March 2018FDA Circular No. 2018-007Reiteration on the Classification of Cuticle Tints Containing Benzalkonium Chloride with Antiseptic, Antibacterial or Disinfectant Claim as Household Remedy
16 March 2018FDA Circular No. 2018-006Reiteration of the Rules and Regulations for Consumer Protection in a Transaction Made Through Electronic Means as Prescribed under the Joint-DOH-DA- Administrative Order No. 01 Series of 2018
16 March 2018FDA Circular No. 2018-005Training Courses / Seminar and Schedule of Fees for the Trainings Offered by the Food and Drug Administration (FDA) Academy - Policy Planning Service (PPS) for Calendar Year 2018
6 March 2018FDA Circular No. 2018-004
Guidelines for Payment of Applications with the Radiation, Regulation Division of the Center for Device, Regulation, Radiation Health and Research

Annex GUIDELINES FOR PAYMENT PORTAL for posting
29 January 2018FDA Circular No. 2018-003 Updates and Amendment of the ASEAN Cosmetic Directive as Adopted During the 27th ASEAN Cosmetic Committee (ACC) Meeting and its Related Meetings
26 January 2018FDA Circular No. 2018-002Training Courses/Seminar and Schedule of Fees for Regional Licensing Seminar for Drugstores and Outlets (LSD-O) and Pharmacovigilance (PV) regulations and Guidelines for PV Officers Offered by the Food and Drug Administration
24 January 2018FDA Circular No. 2018-001Reiteration the Mandatory Implementation of Article 8 of the ASEAN Cosmetic Directive "Product Information"
3 April 2017FDA Circular 2017-001Training Courses/Seminar and Schedule of Fee for the Training Offered by the Food and Drug Administration (FDA) Academy - Policy Planning Service (PPS) for Calendar Year 2017
24 May 2017FDA Circular 2017-001-AAmendment of FDA Circular No. 2017-001
27 June 2017FDA Circular 2017-002 Training Courses/Seminars and Schedule of Fees for the Qualified Person in Industry Regulatory Affairs (QPIRA) Training - Accreditation Offered by the Food and Drug Administration (FDA) Academy - (PPS) for Calendar Year 2017
21 June 2017

FDA Circular 2017-003
Strict Implementation of the Mandatory Requirement to Secure a License to Operate (LTO),Certificate of Product Registration (CPR) or any authorization from FDA Prior to Engaging in the Manufacture, Importation, Exportation, Sale, Offering for Sale, Distribution, Transfer, Promotion, Advertisement and/or Sponsorship of Medical Devices
10 August 2017

FDA Circular 2017-006

Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 25th ASEAN Cosmetic Committee Meeting and Its Related Events
07 August 2017

FDA Circular 2017-007

Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 26th ASEAN Cosmetic Committee Meeting (ACC) and Its Related Events
25 August 2017FDA Circular 2017-008Guidelines on the Requests for Transfer of Payments made to the Food and Drug Administration Offices
25 August 2017FDA Circular 2017-009Guidelines on the Requests for Refund of Payments made to the Food and Drug Administration Offices
15 September 2017FDA Circular 2017-010New Collection Policy and Procedure
26 October 2017FDA Circular 2017-012Training Courses/Seminars and Schedule of Fees for Regional Licensing Seminar for Drugstores and Outlets (LSD-O) Offered by the Food and Drug Administration (FDA) Academy – Policy and Planning Service (PPS) for Calendar Year 2
17 December 2017FDA Circular 2017-014 New Procedure in the Application of the Variation of Certificate of Product Registration for Medical Devices
22 January 2016FDA Circular 2016-001Reiteration of FDA Memorandum Circular No. 2015-003 dated 06 February 2015 and FDA Memorandum Circular No. 2014-014-A of the Guidelines on the Placement of Advertisement in all Forms of Mass and Social Media, Billboards and Pu
06 June 2016FDA Circular 2016-005 Updates and Amendments of the ASEAN Cosmetic Directive as Adopted During the 23rd ASEAN Cosmetic Committee Meeting and Its Related Events
12 July 2016FDA Circular 2016-009Reiteration on the Classification of Diaper Rash Creams / Lotions / Ointments / Powders and Other Products Containing Zinc Oxide
18 July 2016FDA Circular 2016-010New Procedures for Filling of Application for Medical Device Product Registration and Medical Device Establishment License
17 August 2016FDA Circular 2016-010-A Amendment of FDA Circular No. 2016-010: New Procedure for Filling of Application for Medical Device Product Registration and Medical Device Establishment
09 August 2016FDA Circular 2016-013Guidelines on the Implementation of the Joint Food and Drug Administration (FDA) - National Meat Inspection Service (NMIS) Administrative Circular No. 02 on the Transfer of Function in the Regulation of Processed Meat
25 July 2016FDA Circular 2016-012Guidelines on Product Recall
12 August 2016FDA Circular 2016-014Procedure for the use of Electronic Registration (E-Registration) System for Prepackaged Processed Food Products
1 August 2016FDA Circular 2016-015New Procedures for Filing of Application for Certificate of Health Related Device Registration for Water Purification Equipment and Devices and Certificate of Product Registration (CPR) for Equipment or Devices Used for Treati
22 August 2016FDA Circular 2016-016 Updates and Amendments of ASEAN Cosmetic Directive as Adopted During 24 ASEAN Cosmetic Committee Meeting and Its Related Events
04 October 2016FDA Circular 2016-018 New FDA Director General
02 November 2016FDA Circular 2016-020New Procedure for Filing ann Application for an AFR Safety Evaluation Report and Clearance for Customes Release thru the Food and Drug Administration (FDA) Public Assistance, Information, and Receiving (PAIR) of the FDA
28 October 2016FDA Circular 2016-021 New Procedure for Filing an Application for a License to Operate thru the Food and Drug Administration (FDA) Public Assistance, Information, and Receiving (PAIR), Department of Health Regional Field Offices and FDA Regional Of
10 February 2004Bureau Circular No. 02 s. 2004GINKGO BILOBA
25 February 2014FDA Circular No. 2014-007Adoption of the Kuala Lumpur Principles Device Sector Codes of Ethics
16 May 2014FDA Circular No.2014-014Minimum Number of Sample Units Required for Each Test Analysis
02 November 2011FDA Circular No.2011-004Computation of Surcharge or Penalty Imposable in case of Submission of Renewal Applications Covering License of Establishments and Registration of Health Products After Their Date of Expiration Pursuant to Section 3, Paragraphs (A)(2) and (B)(2) of Article I of Book II of the RA 9711 Implementing Rules and Regulations, and Other Purposes
02 May 2016FDA Circular-004Procedure on the Use of the New Application Form for License To Operate (LTO) the the Food and Drug Administration (FDA) Electronic (e-portal)
24 July 1985Administrative Order No. 123-A s. 1985Standard for Banana Sauce
20 November 1996Administrative Order No. 39 s. 1996Amendment to DOH-Administrative Order No. 18-A S. 1993 or the Standards of Quality and Requirements for the processing, packaging and labelling of Bottled drinking water
18 October 1991Officer Order No. 22 s. 1991Guidelines for the Classification of Vitamins and Minerals as Drug or as Food
15 June 2016FDA Circular No. 2016-007Notification of Sources for Raw Materials, Low Risk, Medium Risk and High Risk Prepackaged Processed Food Products
30 May 2013FDA Circular No. 2013-010-AAmendment to FDA Circular No. 2013-010 Revised Guidelines for the Assessment of Microbiological Quality of Processed Foods
27 February 2013FDA Circular No. 2013-010Revised Guidelines for the Assessment of Microbiological Quality of Processed Foods
22 December 2011FDA Memorandum No. 2011-028Safety of Soy Sauce in the Philippines: CODEX Limit on 3 MCPD
28 October 1986Executive Order No. 51Adopting a National Code of Marketing of Breastmilk Substitutes, Breastmilk Supplements, and Related Products.
22 December 1997Bureau Order No. 163 s. 1997Specific Requirements for the Registration of Imported Food and Food Products
27 March 2013Republic Act No. 8172An Act Promoting Salt Iodization Nationwide and for Related Purposes
28 October 2004Bureau Circular No. 17 s. 2004Taheebo / Pau D' Arco / Lapacho
26 October 2004Bureau Circular No. 16 s. 2004Guidelines on Probiotics
15 January 1999Bureau Circular No. 02 s. 1999Amendment to BFAD MC No. 25, s.1992 otherwise known as "Additional Labeling Requirement for Food Supplements"
08 September 2014Administrative Order No. 2014-029Rules and Regulations on the Licensing of Food Establishments and Registration of Processed Food, and the Other Food Products, and for Other Purposes
28 December 2007Administrative Order No. 2007-0044Amendment to Section VIII.3 of Administrative Order No.18-A S. 1993 Dated January 23,1993 entitled Standards of Quality Requirements for the Processing,Packaging and Labelling of Bottled Drinking Water
21 June 2006Administrative Order No. 2005-0016General Policies and Guidelines Governing Brand Names of Products for Registration with the Bureau of Food and Drugs
20 April 1977Administrative Order No. 325 s. 1977Regulation B-4 Definition and Standard for Foods 4.9 Condiments, Sauces and Seasoning 4.9-04 Standard of Identify and Quality for Patis
18 March 2013Administrative Order No. 239 s. 1975Regulation B-4 Definition and Standards of Food B-4.13 Jams (Fruits Preserves) B-4.13-02 Jellies (Naming the Fruits)
04 May 2012FDA Order No. 2012-001Rules of Procedure and Requirements for the Food and Drug Administration 's Accreditation of Private Testing Laboratories
16 December 1974Administrative Order No. 233 s. 1974Regulation B-1 Definitions and Standards for Food B-1.6 Condiments, Sauces, Seasoning B-1.9-01 Tomato Catsup (Catsup)
16 December 1974Administrative Order No. 232 s. 1974Regulation B-4 Definitions and Standards for Food B-4.18 Margarine
20 December 1974Administrative Order No. 231 s. 1974B-4 Definitions and Standards for Food B-4.15 Fats and Oils B-4.15-02 Lard
16 December 1974Administrative Order No. 228 s. 1974B-4 Definitions and Standards for Food B-4.17 Nut Products B-4.17-01 Peanut Butter
12 November 1973Administrative Order No. 200-A s. 1973Regulation B-4 Definitions & Standards of Identity for Foods, B-4.5 Cheese and Cheese Products
30 August 1971Administrative Order No. 154 s. 1971Regulation B-4 Definition and Standards of Identity for Foods; A.14 Meat and Meat Products. A.14.01 Sausages
13 May 2014Administrative Order No. 134 s. 1970Regulation Prescribing the Standard of Identity and Quality of Vinegar (B-4.9 Condiments, Sauces, Seasonings)
20 October 1970Administrative Order No. 132 s. 1970Regulation Prescribing the Standards of Identity and Quality of Milk and Milk Products (B-4.12-01)
24 August 1970Administrative Order No. 128 s. 1970Regulation Prescribing the Standard of Identity and Quality for Bagoong (Fish or Shrimp) B-4.9 03 Condiments, Sauces, Seasonings)
22 August 2014Administrative Order No. 88-A s. 1984Regulatory Guidelines Concerning Food Additives
17 September 2001Administrative Order No. 50 s. 2001Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs
23 July 1993Administrative Order No. 18-A s. 1993Standards of Quality and Requirements for the Processing, Packaging and Labeling of Bottled Drinking Water
08 June 2000BFAD Circular No. 03-A s. 2000Amendment to FDA Circular No. 2 s. of 1982 on the Importation of Semi-Synthetic Antibiotics
Republic Act No. 8976_IRR“AN ACT ESTABLISHING THE PHILIPPINE FOOD FORTIFICATION PROGRAM
AND FOR OTHER PURPOSES
18 October 2010FDA Memorandum Circular No. 2010-020Suspension of Manufacture, Importation,Distribution, and/or Marketing of all rosiglitazone-containing products
18 October 2010FDA Memorandum Circular No. 2010-019Suspension of Manufacture, Importation,Distributiof Sibutramine Products
13 June 1980Administrative Order No. 90-A s. 1980Name of Fruit Beverages
15 June 1989Memorandum Circular No. 13 s. 1989Methanol Content in Alcohol Beverages as defined by Memo-Circular 88-003
11 March 2008Department Circular No. 2008-0064Certain Provisions of Administrative Order No. 2006-0012 declared as ineffective
09 January 2008 Department Circular No. 2008-0006 Labeling of Milk and Milk Products
08 August 2013Republic Act No. 10611Food Safety Act of 2013
22 June 2015FDA Circular No. 2015-005-AAmendment to FDA Circular 2015-005, “Guidelines on the Use of “Saktong Iodine sa Asin” Quality Seal”
15 April 2015FDA Circular No. 2015-005“Guidelines on the Use of “Saktong Iodine sa Asin” Quality Seal”
12 November 1973Administrative Order 200-A s. 1973 Definitions and Standards of Identity for Foods: Cheese and Cheese Products
20 October 1970Administrative Order 132 s. 1970Regulation Prescribing the Standards of Identity, Quality of Milk and Milk Products (B-4.12-01)
29 March 2010FDA Circular No 2010-008Adoption of the Codex Standards on Food Contaminants in Processed Food
13 December 2012 FDA Circular No 2012-015Guidelines on Voluntary Declaration of the front of pack labeling (energy or calorie count) on the labels of processed food products
23 January 2007Bureau Circular No. 2007-002Guidelines in the Use of Nutrition and Health Claims in Food
18 October 2006Bureau Circular No. 2006-016Updated list of food additives
15 May 2006Administrative Order No. 2006-0012Revised Implementing rules and Regulations of Executive Order No. 51, Otherwise known as the "Milk Code"
09 August 2005 Bureau Circular No. 16 s. 2005Adopting the 2002 Recommended Energy and Nutrient Intakes as the new Dietary Standard
16 November 2017FDA Circular No. 2017-013Guidelines on the Issuance of Clearance for Customs Release of Radiation Devices by the Food and Drug Administration - Center for Device Regulation, Radiation Health and Reaserch
11 January 2005Administrative Order No. 2005-0003Guidelines on the Issuance of Certificate of Product Registration for Water Purification Equipment and Devices
25 February 2014FDA Memorandum Circular No. 2014-005Updated List of Medical Devices Required to be Registered Prior to Sale, Distribution and Use
26 January 2018Administrative Order No. 2018-0002Guidelines Governing the Issuance of an Authorization for a Medical Device based on the ASEAN Harmonized Technical Requirements
25 June 2019Administrative Order No. 2019-0019Reinstatement of Requirements of Licensing as Importers, Exporters, Manufacturers, Toll Manufacturers, Wholesalers, Distributors, Retailers or Repackers of those engaged in certain Household/Urban Hazardous Substances, and from the Requirement of Prior Registration and/or Notification of Said Products
09 August 2019FDA Circular No. 2019-004Ban of Bisphenol A (BPA) from Infant Feeding Bottles and Sippy Cups as Child Care Article Products
20 February 2015FDA Circular No. 2015-002Guidelines on the Electronic Notification of the Toys and Childcare Articles(TCCAs)
03 September 2013Republic Act No. 10620An Act Providing for Toy and Game Safety Labeling, Appropriating Funds Therefor
12 July 2016FDA Circular No. 2016-008Recognition of Licenses and Identification (IDs) cards Issued by the Fertilizer and Pesticide Authority (FDA) to Pest Control Operators (PCOs) and Pesticide Applicators, Respectively
08 August 2017FDA Circular No. 2017-005List of Banned Pesticides
27 December 2017FDA Circular No. 2017-015Adoption of the ASEAN Cosmetic Directive (ACD) Annexes II and VI as Standards for Household/Urban Pesticides
18 June 2018FDA Circular No. 2018-008Ban on Chlorpyrifos and Dichlorvos for Use in Household/Urban Pesticide Products and Household/Urban Pesticide Products Containing Chlorpyrifos and Dichlorvos as Active Ingredients
18 June 2019Administrative Order No. 2019-010Guidelines on the Regulation of Operators of Pest Control, Certification of Pesticide Handlers and Accreditation of their Training Providers
14 June 2019Administrative Order No. 2019-0008New Rules and Regulations in the Registration of Household Pesticide Products and Their active Ingredients
31 July 2015FDA Memorandum Circular No. 2015-011Guidelines for Electronic Notification of Cosmetic Products (Cosmetic E-Notification Version 2.0) Using the FDA E-Portal
16 July 2015FDA Memorandum Circular No. 2015-010Guidelines on Issuance of Center for Cosmetic Regulation and Research (CCRR) User account to Access E-Portal
07 May 2012Administrative Order No. 2009-0005-BAddendum to DOH Administrative Order No. 2009-0005 "Revised Policies and Guidelines on the Regulations on the Issuance of a License to Operate (LTO), Certificate of Conformity and Clearance for Customs Release Prescribed to Manufacturers, Importers and Distributors of Toys in the Philippines
14 December 2011Administrative Order No. 2009-005-AAddendum to Administrative Order No. 2009-0005 Revised Policies and Guidelines on the Regulations on the Issuances of a License to Operate (LTO), Certificate of Conformity and Clearance for Customs Release Prescribed to Manufacturers, Importers and Distributors of Toys in the Philippines
12 January 2009Administrative Order No. 2009-0005Revised Policies and Guidelines on the "Regulations on the Issuances of a License to Operate (LTO), Certificate of Conformity and Clearance for Customs Release Prescribed to Manufacturers, Importers and Distributors of Toys in the Philippines
06 October 2005Administrative Order No. 2015-0025Implementation of the (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents
21 April 2005Administrative Order No. 2005-0015Adoption of the Association of Southeast Asia Nation (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents
10 October 2007Bureau Circular No. 2007-010Guidelines in the Initial Issuance and Renewal of License to Operate for Iron Rice Premix Manufacturer / Repacker / Importer and Setting Forth the Standards for Iron Rice Premix
06 October 2005Administrative Order No. 2015-025Implementation of the (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents
21 April 2005Administrative Order No. 2005-015Adoption of the Association of Southeast Asia Nation (ASEAN) Harmonized Cosmetic Regulatory Scheme and ASEAN Common Technical Documents
20 October 2004Bureau Circular No. 15 s.2004Guidelines on Advertising, Promotion, and other Marketing Materials for Breast milk substitutes, Breast milk Supplement, and Other Related Products
20 October 1998 Bureau Circular No. 6-A s. 1998 Permissible Net Content Variation in Pre-Packaged Food
19 July 2005Administrative Order No. 4-A s. 1995Guidelines on Micronutrient Fortification of Processed Foods
28 October 1986 Executive Order 51Adopting a National Code of Marketing of Breastmilk Substitutes, Breastmilk Supplements, and Related Products. It will Take Effect 30 Days after Publication in the Official Gazette
07 September 1982FDA Regulation No. 001-A s. 1982Guidelines for the Open-Date Marking of Liquid Milk Products, Pursuant to A.O. No. 16 S 1979
Administrative Order No. 2014-0030“Revised Rules and Regulations Governing the Labeling of Prepackaged Food Products Further Amending Certain Provisions of Administrative Order No. 88-B s. 1984 or the “Rules and Regulations Governing the Labeling of Prepackaged Food Products Distributed in the Philippines,” and For Other Purposes
Bureau Circular No. 16 s. 2004Guidelines on PROBIOTICS
Republic Act No. 9711AN ACT STRENGTHENING AND RATIONALIZING THE FOOD AND DRUGS (BFAD) BY ESTABLISHING ADEQUATE TESTING LABORATORIES AND FIELD OFFICES, UPGRADING ITS FQUIPMENT, AUGMENTING ITS HUMAN RESOURCE COMPLEMENT, GIVING AUTHORITY TO RETAIN ITS INCOME, RENAMING IT THE FOOD AND DRUG ADMINISTRATION (FDA), AMENDING CERTAIN SECTIONS OF REPUBLIC ACT NO. 3720, AS AMENDED, AND APPROPRIATING FUNDS THEREOF
Department Circular No. 2011-0101The Rules and Regulations Implementing Republic Act No. 9711 -The Food and Drug Administration Act of 2009
FDA Circular No. 2013-018Adoption of the International Conference on Harmonization (ICH) Safety and Efficacy Guidelines
FDA Circular No. 2013-019Organization of the ASEAN Common Technical Dossier (ACTD) for the Registration of Pharmaceutical Products for Human Use
FDA Circular No. 2013-023Clarification on the Provisions of Administrative Order No. 2013-0022, on the Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers
FDA Circular No. 2013-025Amendment of the Product Registration (CPRs) of Drug Products
FDA Circular No. 2013-026Adoption of the ICH Harmonised Tripartite Guideline, Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products Q5C
FDA Circular No. 2013-027Waiver of Initial and Renewal Application Fees for License to Operate as Drug Outlets or Pharmacies in Calamity Areas in Leyte and Eastern Samar until December 31, 2014, and for Other Purposes
FDA Circular No. 2013-028Suspension of Manufacture,Importation, Distribution, and/or Marketing of Ketoconazole Oral Products
FDA Circular No. 2014-008Application Process and Requirements for Post-approval Changes of Pharmaceutical Products
FDA Circular No. 2014-009Filing and Submission of Applications for the Approval of Clinical Trial Protocol, Compassionate Special Permit (CSP), Import Permit for Investigational Drug Products, Pharmacovigilance, Adverse Events/Adverse Reaction Reports
FDA Circular No. 2014-010Sale and Distribution of Empty Gelatin Capsules
FDA Circular No. 2014-013Re-Assessment of the Application of Stem Cell Therapy for Corneal Resurfacing with Limbal Stem Cells
FDA Circular No. 2014-015Manufacture, Sale and Distribution of Traditional and Alternative Medicines
FDA Circular No. 2014-017Procedure in the submission and issuance of the Food and Drug Administration Certification for Animal Feeds and Feed Products
FDA Circular No. 2014-018Manufacture, Sale and Distributiron of Unregistered Medical Grade Oxygen
FDA Circular No. 2014-020Submission of Compliances to Notice of Deficiencies (NODs) Relative to Registration Applications and Corrective Action / Preventive Action (CAPA) Plan based on Inspection Findings
FDA Circular No. 2014-018-AAmendment to FDA Circular No. 2014-018 Dated 15 August 2014 Entitled Manufacture, Sale, and Distribution of Medical-Grade Oxygen
FDA Circular No. 2014-025Guideline on Implementation of New Rules and Regulation on Licensing of Drugstore / Pharmacy / Botica and Similar Outlets following Administrative Order No. 2014-0034, dated 13 October 2014
FDA Circular No. 2014-026Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Distributors following Administrative Order No. 2014-0034, dated 13 October 2014
FDA Circular No. 2014-027Guidelines on the Implementation of New Rules and Regulations on the Licensing of Drug Manufacturer following Administrative Order No. 2014-0034, dated 13 October 2014
FDA Circular No. 2014-028Guideline on the Implementation of New Rules and Regulation on Licensing of Retail Outlet for Non-Prescription Drugs (RONPD's) following Administrative Order No. 2014-0034, dated 13 October 2014
FDA Circular No. 2015-001Clarification on Regulation Governing Principal and Identical Drug Products as defined under Administrative Order No. 2015-0031
FDA Circular No. 2015-004List of Reference Biotherapeutic Products (RBPs) for Head-to-Head Comparability Studies of Similar Biotherapeutic Products (SBPs)
FDA Circular No. 2015-003-AAmendment to FDA Circular No. 2015-003, Guidelines on the Implementation of New Rules and Regulations on the Licensing of Sponsors and Contract Research Organizations (CROs) following Administrative Order No. 2014-0034, dated 13 October 2014
FDA Circular No. 2015-003Guidelines on the Implementation of New Rules and Regulation on the Licensing of Sponsors and Contract Research Organizations (CROs) following Administrative Order No. 2014-0034, dated 13 October, 2014
FDA Circular No. 2015-010Adoptation of the Public Assistance, Information and Receiving (PAIR) Process of the DOH Regional Office XI for License to Operation (LTO) Application
FDA Circular No. 2015-011Guidelines on Implementing FDA Circular No. 2014-011 on Adoptation of Unique Global Product Identification Number for Drug Products
FDA Circular No. 2015-012Additional Requirements for the Effective Implementation of FDA Circular No. 2013-014, List of Products Requiring Bioequivalence (BE) Studies as part of the Application for the Marketing Authorization in Addition to Rifampicin
FDA Circular No. 2015-013Adoptation of the Public Assistance, Information and Receiving (PAIR) Process of the Department of Health (DOH) Regional Office III for License to Operate (LTO) Applications
FDA Circular No. 2016-002Training Course and Schedule of Fees for the training Offered by the Food and Drug Administration (FDA) Academy - Human Resource Development Division for Calendar Year 2016
FDA Circular No. 2016-006New Format of License to Operate (LTO) for Establishments Regulated by the FDA
FDA Circular No. 2014-008-AAmendment to Annex B, Notification for Minor of FDA Circular No. 2014-008 entitled "Application Process and Requirements for Post-Approval Changes of Pharmaceutical Products", Specially on Section IV, C, D, and E for Minor variation-Notification
FDA Circular No. 2016-011Moratorium on the Implementation of FDA Circular No. 2015-011 entitled " Guidelines on Implementing FDA Circular No. 2014-011 on Adoption of Unique Global Product Identification Number for Drug Products"
FDA Circular No. 2016-017Additional Post-Approval Changes for Pharmaceutical Products
FDA Circular No. 2016-019Revised Guidelines on the Submission of Equivalence Evidence for Registration of Pharmaceutical Products
FDA Circular No. 2017-004Reiteration of the Rule on Licensing Application Requiring Prior Inspection Pursuant to Administrative Order No. 2016-0003 dated February 15, 2017
FDA Circular No. 2017-011New Batch Notification Form and Procedure
FDA Circular No. 2018-011Schedule of Unified Licensing Seminar for Calendar Year 2018
FDA Circular No. 2018-012Rescinding FDA Circular No. 2013-004 and Instituting Post-marketing Surveillance (PMS) Requirements for New Drugs under Monitored Release
FDA Circular No. 2018-013Risk Management Plan (RMP) for Drug Establishments
FDA Circular No. 2018-014Validity of Certificates of Product Registration (CPRs) in the Pilot Project Review of the Over-the-Counter Medicines Application (ROTCA) Medicines
Administrative Order No. 2008-0033Rules and Conditions in Exempting Antibiotic Drug Products from the Batch Certification Requirement Amending for this Purpose Item III (C) and (D) of Administrative Order No. 103 s. 2002 "Batch Certification of Antibiotics", and for Other Purposes.
Administrative Order No. 2010-0005Establishment of the National Center for Pharmaceutical Access and Management (NCPAM) Under the Office of the Secretary of Health
Administrative Order No. 2010-0012Policy Requiring the Temporary Suspension of Acceptance by the Food and Drug Administration of Initial Applications for Drug Product Registration and Criteria for Refusal of Applications for Renewal of Drug Products with More than One Hundred (100) Registered Pharmaceutical Formulations
Administrative Order No. 2010-0032Guidelines and Mechanism to Implement the Provisions of Republic Act No. 9994, Otherwise Known as "The Expanded Senior Citizens Act of 2010", on the Sale of Medicines and the Sharing of the 20% Senior Citizens' Discount
Administrative Order No. 2011-0012Implementing Guidelines on Electronic Drug Price Monitoring System (EDPMS) version 2.0
Administrative Order No. 2006-0009Guidelines Institutionalizing and Strengthening the Essential Drug Price Monitoring System (EDPMS)
Administrative Order No. 2012-0024Amendment to A O No. 50 s. 2001 Covering Fees and Charges for Accreditation of Bioequivalence Testing Centers and Private Testing Laboratories, as well as ,Audits and Inspection
Administrative Order No. 1 s. 2000Banning and Withdrawal of Trovafloxacin (Trovan) from the Market
Administrative Order No. 1 s. 2001Granting of Provisional Accreditation to Pharmaceuticals Suppliers
Administrative Order No. 2005-0001Revised Policies and Guidelines Governing Patent and Trade Secret Rights in relation to the Registration of Pharmaceutical Products
Administrative Order No. 3 s. 2001Recalling A.O. No. 99 s. 2000 Providing for the Banning and Withdrawal for the Fixed-Dose Combination Drug Product Loratidine + Pseudoephedrine (Clarinase) from the Market
Administrative Order No. 4 s. 1992Policy and Requirements for Availing of Compassionate Special Permit (CSP) for Restricted Use of Unregistered Drug and Device Product/Preparation
Administrative Order No. 4-A s. 2000Banning and Withdrawal of Olaquindox and Carbadox from the Market
Administrative Order No. 5 s. 1992Banning of Loperamide Hydrochloride Liquid Preparation for Children
Administrative Order No. 7 s. 1986Amending A.O. No. 133 s. 1985 Re: Guidelines on the Evaluation and Registration of Fixed Dose Combination
Administrative Order No. 2005-0008Policy and Requirements for Availing of Special Permit for Restricted Use of Unregistered Drug and Test Kits for Human Immune Deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS)
Administrative Order No. 10 s. 1997Waiver of Test Analysis on Antibiotic Preparations and List B Prime Drugs7
Administrative Order No. 2005-0011Supplemental -Guidelines to Administrative Order No. 144 Series 2004, Entitled ".Guidelines for the Establishment and Operations of Botika ng ''Barangays (BnB) and Pharmaceutical Distribution (PDNs)" Relative to the Inclusion of Other Drugs which are Classified as Prescription Drugs and other Related Matters
Administrative Order No. 13 s. 1999Hydroquinone and/or Tretinoin (Retinoic Acid)
Administrative Order No. 14 s. 1993Non-Compliance with Regional Order No. 26 s. 1992 in Relation to Section 2.2.1.3.5 s. 1989 Dated January 3, 1989 and BFAD Memorandum Circular No.2 s.1993 Re: Cough Syrup Containing Dextromethorpan
Administrative Order No. 19 s. 1998Delisting Dipyrone in the Registry of Drugs with the Bureau of Food and Drugs (BFAD)
Administrative Order No. 14 s. 2001Interim Accreditation Guidelines for DOH Drugs and Medicines Suppliers
Administrative Order No. 16 s. 1999Delisting Oral Proteolytic Enzyme-Containing Drug Products in the Registry of Drugs with the Bureau of Food and Drugs (BFAD)
Administrative Order No. 19 s. 1998Delisting Dipyrone in the Registry of Drugs with the Bureau of Food and Drugs (BFAD)
Administrative Order No. 23 s. 2000Implementing Rules and Regulations of Republic Act No. 8423 Otherwise Known as The Traditional and Alternative Medicine Act of 1997
Administrative Order No. 23-A s. 1996Guidelines on the Development and Establishment of Botica ng Barangay (BNB)
Administrative Order No. 23-C s. 2000Policies and Guidelines on Over-The-Counter (OTC) Drug Products
Administrative Order No. 27 s. 2001Rules and Regulations for Licensing Local Manufacturers of Vaccines and Biologic Products
Administrative Order No. 28 s. 1996Standard Minimum Advertising Message for Anti-Diarrheal Preparations of Drug Products
Administrative Order No. 2005-0030Guidelines and Procedure For the Automatic Renewal of the Certificate of Product Registration issued by the Bureau of Food and Drugs
Administrative Order No. 31 s. 1996Guidelines in the Strengthening of the Implementation of the "Project Murang Gamot Presyong DOH"
Administrative Order No. 2005-0031Guidelines and Procedure For the Issuance of the Principal Certificate of Product Registration and the Listing of Identical Drug Products based on the Identity of Manufacturer and Pharmaceutical Formulation
Administrative Order No. 32 s. 1987Further Amending Administrative Order No. 101 s. 1969 Relative to Registration of Drugs and Pharmaceutical Specialties
Administrative Order No. 33 s. 1982Reclassifying Ephedrine And Ephedrine-Containing Cough Syrup From “Over-The-Counter” Drugs to Prescription Drugs
Administrative Order No. 2007-0006Amendment to Administrative Order No.46 s.1988 Re: Organizational Arrangements to Implement the National Drug Policy
Administrative Order No. 23-A s. 1996Guidelines on the Development and Establishment of Botica ng Barangay (BNB)
Administrative Order No. 2006-0021Supplemental Guidelines to Administrative Order (AO) 67 s.1987, Revised Rules and Regulation on Registration of Pharmaceutical Products and Bureau Circular 05 s.1997 in Evaluating New Drug Applications
Administrative Order No. 341 s. 1978Ban on the Use of Chloroform (Trichloromathane)
Administrative Order No. 283 s. 1976Banning and Withdrawal of Penicillin For Topical Application
Administrative Order No. 220 s. 1974Current Good Manufacturing Practice in Manufacture, Processing, Packaging or Holding
Administrative Order No. 194 s. 1973Ban on the Use of Diethylstilbestrol (DES)
Administrative Order No. 184 s. 2004Guidelines on the Registration of Traditionally-Used Herbal Products
Administrative Order No. 179 s. 1972Restricted Use of Hexachlorophene
Administrative Order No. 178 s.1972Withdrawal of Dihydrostreptomycin from All Pharmaceutical Products Intended for Human Use
Administrave Order No. 172 s. 2004Guidelines on the Registration of Herbal Medicines
Administrative Order No. 170-2004Policies and Guidelines Governing Intellectual Property Rights in Relation to Registration of Pharmaceutical Products
Administrative Order No. 2013-012Rules and Regulations Governing the Accreditation of Health Facilities Engaging in Human Stem Cell and Cell-Based or Cellular Therapies in the Philippines
Administrative Order No.163-2000Reclassifying All Pharmaceutical Products containing more than 25 mg to 50 mg of Phenylpropanolamine to Prescription drugs and Prohibiting the Registration of those containing more than 50 mg
Administrative Order No. 2012-0008Adoption and Implementation of the Pharmaceutical Inspection Cooperation Scheme (PIC/S) Guides for the Good Manufacturing Practice(GMP) for Medicinal Products
FDA Circular No.2019-003Guidelines for The Classification of Deficiencies Observed During Inspection of Drug Manufacturers
FDA Circular No. 2014-016Implementing Guidelines for Administrative Order No. 2013-0022 dated 13 August 2013, Subject: Guidelines for Current Good Manufacturing Practice (cGMP) Clearance and Inspection of Foreign Drug Manufacturers
JOINT DOH and DA Administrative Order No. 2013-0026Rules on the Regulation of Veterinary Drugs and Products, Veterinary Biological Products, and Veterinary Drugs Establishments
Administrative Order No. 2013-0027Adoption and Implementation of the World Health Organization Annex 5 Guide to Good Distribution Practices (GDP) for Pharmaceutical Products, and Annex 9 Guide to Good Storage Practices for Pharmaceuticals
Administrative Order No. 34 s. 1979The Need and Role of a Medical Director in the Pharmaceutical Industry
Administrative Order 2014-0016Adoption of the World Health Organization "Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs) for the Registration of Biosimilar Products
Administrative Order No. 2011-0009National Policy and Program on Pharmacovigilance
Administrative Order No. 144 s. 2004Guidelines for the Establishment and Operations of Botika ng Barangay (BnB) and Pharmaceutical Distribution Networks (PDNs)
Administrative Order No. 142 s. 2004Bureau of Food and Drugs (BFAD)'s issuance of Certificate of Product Registration for Foreign Assisted Projects Procurement and Laboratory Testing Pharmaceutical and Biological Products Procured by and/or Delivered to the Department of Health (DOH)
Administrative Order No. 64 s. 2003Policy Guidelines on the Operationalization of Botika ng Barangays (BnBs) by the Center for Health Development (CHD)
Administrative Order No. 34 s. 2003Guidelines in the Operationalization of Botika ng Barangay at CHD III Pilot Areas
Administrative Order No. 103 s. 2002Batch Certification of Antibiotics
Administrative Order No. 70 s. 2002Licensing of Botika ng Barangay (BnB) in Various Local Government Units
Administrative Order No. 53 s. 2001Recalling Administrative Order No. 40 s. 2001
Administrative Order No. 149 s. 1971Unauthorized Purchase, Possession, Display or Sale of Government-Owned Drugs, Medicines or Any Other Medicinal Items
Administrative Order No. 131 s. 1970Regulation Part C-3.2: Drugs: Prohibition of Use of More Than One Name for a Given Formulation
Administrative Order No. 151 s. 1971Regulation Part C-7 Drug and Devices: Certification of Antibiotics
Administrative Order No. 342 s. 1978Banning Tetracyclines for Children Under 8 years Old
Administrative Order No. 96-A s. 1980Supplementing Administrative Order No. 81, 88 and 94 s. 1980 dated March 26, May 22 and July 10, 1980: Re-authorized ceiling of drugs and medicines that can be kept in stock by hospitals and sanitaria
Administrative Order No. 24-A s. 1982Banning Neomycin in Anti-diarrheal Preparations
Administrative Order No. 129 s. 1985Banning and Withdrawal of Flosint Tablets (Indoprofen) from the Market
Administrative Order No. 130 s. 1985Banning and Withdrawal of Sulocton (Suloctidil) from the Market
Administrative Order No. 64 s. 1989Amendment of A.O No. 55 s. 1988 Otherwise Known as Requirements for Labelling Materials of Pharmaceutical Products
Administrative Order No. 147 s. 1986Banning and Withdrawal of Merital 25/50 mg Capsules (Nomifensine)
Administrative Order No. 70 s. 1989Re-Classifying Pseudoephedrine and Drug Products Containing Pseudoephedrine as Prescription Drugs
Administrative Order No. 91 s. 1990Declaring a Ban or the Use of Chloramphenicol in Food Producing Animals
Administrative Order No. 93 s. 1990Postponement of the Deadlines of A.O 85 s. 1990
Administrative Order No. 100 s. 1990Regulation for the Licensing of Veterinary Drug and Product Establishments and Outlets
Administrative Order No. 111-D s. 1991Guidelines on Advertisement and Promotions of Veterinary Drugs and Products
Administrative Order No. 113 s. 1991Guidelines on Advertisement and Promotion of Multi-active Ingredient/Fixed Dose Combination Drug Products
Administrative Order No. 41 s. 1994Supplemental Rules and Regulations in Registration of Pharmaceutical Products Entitled to a Conditional Certificate of Product Registration
Administrative Order No. 8-A s. 1995One-Stop-Shop Licensing Unit for Hospitals and Medical Ancillary Services
Administrative Order No. 63 s. 2000Guidelines in the Filling of Ordinary Prescriptions (Rx) by all Drug Outlets (Drugstore, Pharmacy or Botica Including Hospital Pharmacy/Dispensary)
Administrative Order No. 86 s. 2000The Need and Role of a Medical Director in the Pharmaceutical Industry
Administrative Order No. 176 s. 2004Guidelines in the Use of Albendazole or Mebendazole in the Treatment of Soil-Transmitted Helminthiasis in Children 12 Months Old and Above
Administrative Order No. 2012-0007GUIDELINES ON THE GRANT OF TWENTY PERCENT (20%) DISCOUNT TO SENIOR CITIZENS ON HEALTH RELATED GOODS AND SERVICES AND FOR OTHER PURPOSES
Administrative Order No. 42Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines
Administrative Order No. 2014-0034Rules and Regulations on the Licensing of Establishments Engaged in the Manufacture, Conduct of Clinical Trial, Distribution, Importation, Exportation, and Retailing of Drug Products, and Issuance of Other Related Authorizations
Administrative Order No. 2014-0040REVISED GUIDELINE ON THE NEED / ROLE OF A MEDICAL DIRECTOR IN THE PHARMACEUTICAL INDUSTRY
Administrative Order No. 42Creating an Inter-Agency Committee for the Formulation and Implementation of a National Plan to Combat Antimicrobial Resistance in the Philippines